Skip to content

Comparative measurements of Intestinal permeability by using urine Lactulose/Mannitol ratio between patient with Functional bloating or bloating predominant FGIDs, Inflammatory bowel disease (IBD) and healthy volunteer

Comparative measurements of Intestinal permeability by using urine Lactulose/Mannitol ratio between patient with Functional bloating or bloating predominant FGIDs, Inflammatory bowel disease (IBD) and healthy volunteer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200203001
Enrollment
36
Registered
2020-02-03
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal permeability Gastrointestinal symptoms Intestinal permeability Urine Lactulose and Mannitol ratio Bloating Crohn’s disease

Interventions

All participants were overnight fasted and morning urine samples were collected as baseline. After ingestion of 100 ml solution of 5 g lactulose and 2 g mannitol in water&#44
urine samples were serially collected at 2&#44
4 and 6 hour. ,All participants were overnight fasted and morning urine samples were collected as baseline. After ingestion of 100 ml solution of 5 g lactulose and 2 g mannitol in water&#44
4 and 6 hour.
Measurement of percentage excretion of urine lactulose and mannitol in healthy volunteer,Measurement of percentage excretion of urine lactulose and mannitol in functional bloating,Measurement of perce

Sponsors

Siriraj Medical Research Ceter (SiMR)
Lead Sponsor
Division of Gastroenterology&#44
Collaborator
Department of Medicine&#44
Collaborator
Siriraj hospital&#44
Collaborator
Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 Age 18-65 year 2 Population group 2.1 Healthy Or 2.2 Patient with Functional bloating or Functional gastro-intestinal disorder From Rome IV criteria Or 2.3 Patient with small bowel Crohn’s disease with disease activity from CDAI >= 220

Exclusion criteria

Exclusion criteria: 1 Previous bowel resection 2 Uncontrolled underlying diseases 3 Active smoking or drinking 4 Using medications included NSIADs, antispasmodic and prokinetics agents within 2 weeks prior to study.

Design outcomes

Primary

MeasureTime frame
Intestinal permeability 2, 4 and 6 hours after ingestion ratio of percentage excretion of lactulose and mannitol in urine (uLMR)

Secondary

MeasureTime frame
Symptoms and Quality of life Before and after Modified GIS rating scale and GIQoL ,Safety and tolerability After Symptoms

Contacts

Public ContactMonthira Maneerattanaporn

Division of Gastroenterology, Department of Medicine, Siriraj hospital, Mahidol University

Monthira.man@mahidol.ac.th66-24197281

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026